Common use of Arrangements Transactions Review Clause in Contracts

Arrangements Transactions Review. The Arrangements Transactions Review shall consist of a review by the IRO of 50 randomly selected Focus Arrangements that were entered into or renewed by the DIG Entities during the Reporting Period or 20% of such Focus Arrangements, whichever is less. The IRO shall assess whether the DIG Entities has complied with the Focus Arrangements Procedures and the Focus Arrangements Requirements described in Sections III.D.1 and III.D.2 of the CIA, with respect to the selected Focus Arrangements. The IRO’s assessment with respect to each Focus Arrangement that is subject to review shall include: 1. verifying that the Focus Arrangement is maintained in the DIG Entities’ centralized tracking system in a manner that permits the IRO to identify the parties to the Focus Arrangement and the relevant terms of the Focus Arrangement (i.e., the items/services/equipment/space to be provided, the amount of compensation, the effective date, the expiration date, etc.) 2. verifying that the Focus Arrangement was subject to the internal review and approval process (including both a legal and business review) and obtained the necessary approvals and that such review and approval is appropriately documented; 3. verifying that the remuneration related to the Focus Arrangement is properly tracked; 4. verifying that the service and activity logs are properly completed and reviewed (if applicable); 5. verifying that leased space, medical supplies, medical devices, and equipment, and other patient care items are properly monitored (if applicable); and 6. verifying that the Focus Arrangement satisfies the Focus Arrangements Requirements of Section III.D.2 of the CIA.

Arrangements Transactions Review. The Arrangements Transactions Review shall consist of a review by the IRO of 50 or 10%, whichever is less, randomly selected Focus Arrangements that were entered into or renewed by the DIG Entities FHS or an FHS Entity during the Reporting Period or 20% of such Focus Arrangements, whichever is lessPeriod. The IRO shall assess whether the DIG Entities FHS has complied with the Focus Arrangements Procedures and the Focus Arrangements Requirements described in Sections III.D.1 and III.D.2 of the CIA, with respect to the selected Focus Arrangements. Arrangements.‌ The IRO’s assessment with respect to each Focus Arrangement that is subject to review shall include:include:‌ 1. verifying that the Focus Arrangement is maintained in the DIG Entities’ FHS’s centralized tracking system in a manner that permits the IRO to identify the parties to the Focus Arrangement and the relevant terms of the Focus Arrangement (i.e., the items/services/equipment/space to be provided, the amount of compensation, the effective date, the expiration date, etc.)etc.);‌‌ 2. verifying that the Focus Arrangement was subject to the internal review and approval process (including both a legal and business review) and obtained the necessary approvals and that such review and approval is appropriately documented;documented;‌ 3. verifying that the remuneration related to the Focus Arrangement is properly tracked;tracked;‌ 4. verifying that the service and activity logs are properly completed and reviewed (if applicable);applicable);‌ 5. verifying that leased space, medical supplies, medical devices, and equipment, and other patient care items are properly monitored (if applicable); andand‌ 6. verifying that the Focus Arrangement satisfies the Focus Arrangements Requirements of Section III.D.2 of the CIA.CIA.‌

Arrangements Transactions Review. The Arrangements Transactions Review shall consist of a review by the IRO of 50 a randomly selected Focus Arrangements that were entered into or renewed by sample of the DIG Entities during the Reporting Period or 20% lesser of such either: (a) 20 Focus Arrangements, whichever is less; or (b) 20 percent of Focus Arrangements. The IRO shall assess whether the DIG Entities Exactech has complied with the Focus Arrangements Procedures and the Focus Arrangements Requirements described in Sections III.D.1 III.D.l and III.D.2 of the CIA, with respect to the selected Focus Arrangements. The IRO’s assessment with respect to each Focus Arrangement that is subject to review shall include: 1. verifying that the Focus Arrangement is maintained in the DIG Entities’ Exactech’s centralized tracking system in a manner that permits the IRO to identify the parties to the Focus Arrangement and the relevant terms of the Focus Arrangement (i.e., the items/services/equipment/space to be provided, the amount of compensation, the effective date, the expiration date, ; etc.) 2. verifying that the Focus Arrangement was subject to the internal review and approval process (including both a legal and business review) and obtained the necessary approvals and that such review and approval is appropriately documented; 3. verifying that the remuneration related to the Focus Arrangement is properly tracked; 4. verifying that the service and activity logs are properly completed and reviewed (if applicable); 5. verifying that leased space, medical supplies, medical devices, and equipment, and other patient care items are properly monitored (if applicable); and 6. verifying that the Focus Arrangement satisfies the Focus Arrangements Requirements of Section III.D.2 of the CIA.

Arrangements Transactions Review. The Arrangements Transactions Review shall consist of a review by the IRO of 50 75 randomly selected Focus Arrangements that were entered into or renewed by the DIG Entities OFX or OSI during the Reporting Period Period. The 75 Focus Arrangements shall be divided into two strata. The first stratum shall consist of 40 Arrangements between OFX or 20% OSI and physicians. The second stratum shall consist of such Focus Arrangements, whichever is less35 Arrangements between OFX or OSI and any other source of federal health care program referrals. The IRO shall assess whether the DIG Entities Orthofix has complied with the Focus Arrangements Procedures and the Focus Arrangements Requirements described in Sections III.D.1 III.D.2 and III.D.2 3 of the CIA, with respect to the selected Focus Arrangements. The IRO’s assessment with respect to each Focus Arrangement that is subject to review shall include: 1. verifying that the Focus Arrangement is maintained in the DIG Entities’ Orthofix’s centralized tracking system in a manner that permits the IRO to identify the parties to the Focus Arrangement and the relevant terms of the Focus Arrangement (i.e., the items/services/equipment/space to be provided, the amount of compensation, the effective date, the expiration date, etc.) 2. verifying that the Focus Arrangement was subject to the internal review and approval process (including both a legal and business review) and obtained the necessary approvals and that such review and approval is appropriately documented; 3. verifying that the remuneration related to the Focus Arrangement is properly tracked; 4. verifying that the service and activity logs are properly completed and reviewed (if applicable); 5. verifying that leased space, medical supplies, medical devices, and equipment, and other patient care items are properly monitored (if applicable); and 6. verifying that the Focus Arrangement satisfies the Focus Arrangements Requirements of Section III.D.2 and 3 of the CIA.